Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2026-05-22 @ 1:50 AM
Study NCT ID:
NCT03409432
Status:
COMPLETED
Last Update Posted:
2025-07-25
First Post:
2018-01-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma
Sponsor:
Organization: